Navigation Links
Can Blood Test Predict Breast Cancer Risk?

TUESDAY, May 1 (HealthDay News) -- A blood test that spots changes in a specific gene could reveal a woman's risk for breast cancer years before the disease has a chance to develop, researchers report.

British scientists analyzed blood samples from 640 breast cancer patients and 741 women without breast cancer. The samples from the breast cancer patients were collected an average of three years before they were diagnosed with the disease.

The objective was to find out if the alteration of single genes by a process called methylation could predict a woman's breast cancer risk.

The researchers found that women with the highest level of methylation on one area of a gene called ATM were two times more likely to develop cancer than those with the lowest level of methylation. Methylation is a critical process where chemicals known as "methyl groups" are added to DNA, to make sure everything is in good working order. High levels of methylation signal high levels of DNA trouble.

This result was particularly pronounced in blood samples taken from women under the age of 60, Dr. James Flanagan, a Breast Cancer Campaign scientific fellow in the department of surgery and cancer at Imperial College London, said in a news release from the Breast Cancer Campaign.

The study was published May 1 in the journal Cancer Research.

Unlike previous studies that took blood from breast cancer patients after diagnosis, these blood samples identified alterations in the ATM gene that did not occur because of having active cancer or cancer treatments.

The findings provide strong evidence that looking for this type of alteration in individual genes could be used as a blood test to help predict a woman's chances of developing breast cancer, the researchers said.

Used in combination with other breast cancer risk assessment tools such as genetic testing and risk factor profiling, this blood test could help identify women at higher risk. This early warning could be used to monitor these patients and one day perhaps even prevent them from developing breast cancer.

"We know that genetic variation contributes to a person's risk of disease. With this new study, we can now also say that epigenetic variation, or differences in how genes are modified, also has a role," Flanagan said.

"We hope that this research is just the beginning of our understanding about the epigenetic component of breast cancer risk, and in the coming years we hope to find many more examples of genes that contribute to a person's risk. The challenge will be how to incorporate all of this new information into the computer models that are currently used for individual risk prediction," he noted.

"So far, we have found alterations in one small region of a gene that appear to associate with risk of disease, and so the next step with this epigenetic research is a genome-wide approach to try and find all the associated genes," Flanagan explained.

More information

The American Cancer Society has more about breast cancer risk factors.

-- Robert Preidt

SOURCE: Breast Cancer Campaign, news release, May 1, 2012

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Blood Clot Risk for Outpatients Needs More Attention: Study
2. Stopping Blood Thinners Raises Stroke Risk for Patients With Irregular Heartbeat
3. Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy
4. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
5. Exercise May Help Patients With High Blood Pressure Live Longer
6. Diabetes Groups Issue New Guidelines on Blood Sugar
7. Naturopathic care can improve blood sugar, mood in diabetes
8. Researchers Develop Blood Test for Depression
9. Changes in gene expression may help explain high blood pressure in pregnancy
10. High Blood Pressure May Be Especially Lethal for Blacks
11. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
Post Your Comments:
Related Image:
Can Blood Test Predict Breast Cancer Risk?
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: